Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

Research analysts at William Blair issued their Q2 2025 EPS estimates for shares of Affirm in a research report issued to ...

SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...

William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...

William Blair last night initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating. Sterling’s “industry-leading” data ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...

William Blair Small-Mid Cap Core Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's strong long-term risk-adjusted performance. This can be seen ...

CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...